Literature DB >> 32091351

Identification of a norovirus outbreak on a hematopoietic stem cell transplant unit and development and implementation of a novel infection prevention algorithm for controlling transmission.

Westyn Branch-Elliman1,2,3, Roger V Araujo-Castillo4, Graham M Snyder5, Bernadette F Sullivan6, Carolyn D Alonso3,7, Sharon B Wright3,6,7.   

Abstract

Controlling norovirus transmission in units with immunocompromised patients is challenging. We present a cluster of norovirus cases that occurred on a stem-cell transplant unit and the prevention efforts that were implemented to limit the outbreak. Protocols developed to control this cluster may provide a model for other facilities.

Entities:  

Year:  2020        PMID： 32091351      PMCID： PMC7483699          DOI： 10.1017/ice.2020.21

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  18 in total

1.  Norovirus GII.4 detection in environmental samples from patient rooms during nosocomial outbreaks.

Authors:  Nancy P Nenonen; Charles Hannoun; Lennart Svensson; Kjell Torén; Lars-Magnus Andersson; Johan Westin; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

2.  Underutilization of norovirus testing in hematopoietic cell transplant recipients at a large cancer center.

Authors:  Trenton J MacAllister; Zach Stednick; Jonathan L Golob; Meei-Li Huang; Steven A Pergam
Journal:  Am J Infect Control       Date:  2017-07-27       Impact factor: 2.918

3.  Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation.

Authors:  Stefan Schwartz; Maria Vergoulidou; Eckart Schreier; Christoph Loddenkemper; Mark Reinwald; Martin Schmidt-Hieber; Willy A Flegel; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

Review 4.  A review of nosocomial norovirus outbreaks: infection control interventions found effective.

Authors:  J D Greig; M B Lee
Journal:  Epidemiol Infect       Date:  2012-01-04       Impact factor: 2.451

5.  An outbreak of norovirus infection in a bone marrow transplant unit.

Authors:  Manish Doshi; Simone Woodwell; Kimberly Kelleher; Kenneth Mangan; Peter Axelrod
Journal:  Am J Infect Control       Date:  2013-02-15       Impact factor: 2.918

Review 6.  Norovirus infection in immunocompromised hosts.

Authors:  K Y Green
Journal:  Clin Microbiol Infect       Date:  2014-08       Impact factor: 8.067

7.  A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection.

Authors:  Hoonmo L Koo; Nadim J Ajami; Zhi-Dong Jiang; Herbert L Dupont; Robert L Atmar; Debra Lewis; Patricia Byers; Paula Abraham; Ricardo A Quijano; Daniel M Musher; Edward J Young
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

8.  Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome.

Authors:  Joseph Delano F Robles; Daniel Ka Leung Cheuk; Shau Yin Ha; Alan Kwok Shing Chiang; Godfrey Chi Fung Chan
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-10       Impact factor: 5.742

Review 9.  Norovirus gastroenteritis in immunocompromised patients.

Authors:  Karin Bok; Kim Y Green
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

10.  Sources of Airborne Norovirus in Hospital Outbreaks.

Authors:  Malin Alsved; Carl-Johan Fraenkel; Mats Bohgard; Anders Widell; Anna Söderlund-Strand; Peter Lanbeck; Torsten Holmdahl; Christina Isaxon; Anders Gudmundsson; Patrik Medstrand; Blenda Böttiger; Jakob Löndahl
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079
View more
  1 in total

Review 1.  The Science Behind Safe School Re-opening: Leveraging the Pillars of Infection Control to Support Safe Elementary and Secondary Education During the COVID-19 Pandemic.

Authors:  Elissa M Schechter-Perkins; Polly van den Berg; Westyn Branch-Elliman
Journal:  Open Forum Infect Dis       Date:  2021-03-17       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.